Published in Risk Anal on August 01, 2007
Bacteriophage biocontrol in animals and meat products. Microb Biotechnol (2009) 1.12
Economic evidence on the health impacts of climate change in europe. Environ Health Insights (2014) 0.76
Evaluation of a protective effect of in ovo delivered Campylobacter jejuni OMVs. Appl Microbiol Biotechnol (2016) 0.75
Standardizing the inclusion of indirect medical costs in economic evaluations. Pharmacoeconomics (2011) 2.10
Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med (2008) 2.07
Effect of hemodiafiltration on quality of life over time. Clin J Am Soc Nephrol (2012) 1.50
The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study. Nephrol Dial Transplant (2013) 1.49
Preventive exercises reduced injury-related costs among adult male amateur soccer players: a cluster-randomised trial. J Physiother (2013) 1.48
Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr (2006) 1.34
DALY calculation in practice: a stepwise approach. Int J Public Health (2014) 1.32
Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr (2006) 1.27
Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health (2014) 1.25
New methodology for estimating the burden of infectious diseases in Europe. PLoS Med (2012) 1.21
Risk factors for campylobacteriosis of chicken, ruminant, and environmental origin: a combined case-control and source attribution analysis. PLoS One (2012) 1.18
The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases. PLoS One (2013) 1.17
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health (2014) 1.17
Systematic review of general burden of disease studies using disability-adjusted life years. Popul Health Metr (2012) 1.14
Risk-based estimate of effect of foodborne diseases on public health, Greece. Emerg Infect Dis (2011) 1.13
Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio. Health Econ (2007) 1.11
Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care. BMC Fam Pract (2014) 1.11
Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review. Pharmacoeconomics (2006) 1.06
Systematic review of foodborne burden of disease studies: quality assessment of data and methodology. Int J Food Microbiol (2013) 1.03
Infectious disease risks associated with occupational exposure: a systematic review of the literature. Occup Environ Med (2011) 1.03
A risk assessment model for Campylobacter in broiler meat. Risk Anal (2007) 1.03
Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine (2010) 1.01
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg (2010) 0.99
Effectiveness and efficiency of controlling Campylobacter on broiler chicken meat. Risk Anal (2007) 0.98
Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution. Br J Clin Pharmacol (2007) 0.95
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA. PLoS One (2010) 0.94
Cost-effectiveness of preoperative screening and eradication of Staphylococcus aureus carriage. PLoS One (2011) 0.93
Propidium monoazide does not fully inhibit the detection of dead Campylobacter on broiler chicken carcasses by qPCR. J Microbiol Methods (2013) 0.91
Disability adjusted life years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens. Popul Health Metr (2008) 0.90
Willingness to participate in a lifestyle intervention program of patients with type 2 diabetes mellitus: a conjoint analysis. Patient Prefer Adherence (2011) 0.90
The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open (2011) 0.90
A structured expert judgment study for a model of Campylobacter transmission during broiler-chicken processing. Risk Anal (2005) 0.90
DIRECT trial. Diverticulitis recurrences or continuing symptoms: Operative versus conservative treatment. A multicenter randomised clinical trial. BMC Surg (2010) 0.89
Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial. BMC Cancer (2010) 0.89
The Key Events Dose-Response Framework: its potential for application to foodborne pathogenic microorganisms. Crit Rev Food Sci Nutr (2009) 0.89
Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment. BMC Public Health (2013) 0.89
A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components. Nephrol Dial Transplant (2010) 0.88
Preventing Campylobacter at the source: why is it so difficult? Clin Infect Dis (2013) 0.87
Integrated approaches for the public health prioritization of foodborne and zoonotic pathogens. Risk Anal (2009) 0.87
Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP. BMC Infect Dis (2013) 0.86
Effectiveness and cost-effectiveness of an injury prevention programme for adult male amateur soccer players: design of a cluster-randomised controlled trial. Inj Prev (2010) 0.86
Practicalities of using non-local or non-recent multilocus sequence typing data for source attribution in space and time of human campylobacteriosis. PLoS One (2013) 0.85
A model for the early identification of sources of airborne pathogens in an outdoor environment. PLoS One (2013) 0.85
Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine (2006) 0.85
Protein-energy nutritional status and kidney disease-specific quality of life in hemodialysis patients. J Ren Nutr (2010) 0.84
Clinical performance targets and quality of life in hemodialysis patients. Blood Purif (2011) 0.84
Development of methodology for disability-adjusted life years (DALYs) calculation based on real-life data. PLoS One (2013) 0.84
Cross-contamination during food preparation: a mechanistic model applied to chicken-borne Campylobacter. Risk Anal (2007) 0.83
The cost-effectiveness of increasing alcohol taxes: a modelling study. BMC Med (2008) 0.83
Poultry culling and Campylobacteriosis reduction among humans, the Netherlands. Emerg Infect Dis (2012) 0.83
Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2). BMC Public Health (2009) 0.83
Psychosocial determinants of parents' intention to vaccinate their newborn child against hepatitis B. Vaccine (2012) 0.83
Beyond the neglect of psychological consequences: post-traumatic stress disorder increases the non-fatal burden of injury by more than 50%. Inj Prev (2010) 0.83
Public health services and cost-effectiveness analysis. Annu Rev Public Health (2008) 0.82
The impact of a healthy lifestyle on Disability-Adjusted Life Years: a prospective cohort study. BMC Med (2015) 0.82
Correction: World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis. PLoS Med (2015) 0.81
Changes in quality of life over time--Dutch haemodialysis patients and general population compared. Nephrol Dial Transplant (2010) 0.81
The effect of out-of-pocket costs and financial rewards in a discrete choice experiment: an application to lifestyle programs. BMC Public Health (2014) 0.81
Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates. PLoS One (2013) 0.80
Optimisation of ISO 10705-1 on enumeration of F-specific bacteriophages. J Virol Methods (2002) 0.80
Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature. Surg Endosc (2011) 0.78
Scoping the impact of changes in population age-structure on the future burden of foodborne disease in the Netherlands, 2020-2060. Int J Environ Res Public Health (2013) 0.78
Graphical models and Bayesian domains in risk modelling: application in microbiological risk assessment. Prev Vet Med (2013) 0.78
Gene expression profiles induced by Salmonella infection in resistant and susceptible mice. Microbes Infect (2011) 0.76
Costs and effects of prenatal screening methods for Down syndrome and neural tube defects. Community Genet (2008) 0.76
Differences in quality of life of hemodialysis patients between dialysis centers. Qual Life Res (2011) 0.75
"Second-order modeling of variability and uncertainty in microbial hazard characterization," A comment on: J. Food Prot. 70(2):363-372 (2007). J Food Prot (2007) 0.75
Variability and uncertainty analysis of the cross-contamination ratios of salmonella during pork cutting. Risk Anal (2012) 0.75
Risk based microbiological criteria for Campylobacter in broiler meat in the European Union. Int J Food Microbiol (2012) 0.75
What Are the Costs of Corneal Cross-linking for the Treatment of Progressive Keratoconus? J Refract Surg (2016) 0.75
[Screening for abdominal aortic aneurysm; effectivity and cost-effectiveness]. Ned Tijdschr Geneeskd (2009) 0.75